| 2012 Brazilian Society of Rheumatology Consensus on the management of comorbidities in patients with rheumatoid arthritis. | |
| | |
MedLine Citation:
|
PMID: 22885417 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To elaborate recommendations of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology (SBR) to manage comorbidities in rheumatoid arthritis (RA). METHODS: To review the literature and the opinions of the SBR RA Committee experts. RESULTS AND CONCLUSIONS: Recommendations: 1) Early diagnosis and proper treatment of comorbidities are recommended; 2) The specific treatment of RA should be adapted to the presence of comorbidities; 3) Angiotensin-converting-enzyme inhibitors or angiotensin II receptor blockers are preferred to treat systemic arterial hypertension; 4) In patients diagnosed with rheumatoid arthritis and diabetes mellitus, the continuous use of a high cumulative dose of corticoids should be avoided; 5) Statins should be used to maintain LDL cholesterol levels under 100 mg/dL and the atherosclerotic index lower than 3.5 in patients with RA who have other comorbidities; 6) Metabolic syndrome should be treated; 7) Performing non-invasive tests to investigate subclinical atherosclerosis is recommended; 8) Greater surveillance for the early diagnosis of occult malignancy is recommended; 9) Preventive measures of venous thrombosis are suggested; 10) Bone densitometry is recommended in RA patients over the age of 50 years and in younger patients on corticoid therapy at a dose greater than 7.5 mg for over three months; 11) Patients with RA and osteoporosis should be instructed to avoid falls, to increase their dietary calcium intake and sun exposure, and to exercise; 12) Calcium and vitamin D supplementation is suggested. Bisphosphonates are suggested for patients with T score < -2.5 on bone densitometry; 13) A multidisciplinary team, with the active participation of a rheumatologist, is recommended to treat comorbidities. |
| | |
Authors:
|
Ivânio Alves Pereira; Licia Maria Henrique da Mota; Boris Afonso Cruz; Claiton Viegas Brenol; Lucila Stange Rezende Fronza; Manoel Barros Bertolo; Max Victor Carioca de Freitas; Nilzio Antônio da Silva; Paulo Louzada-Junior; Rina Dalva Neubarth Giorgi; Rodrigo Aires Corrêa Lima; Geraldo da Rocha Castelar Pinheiro; |
Related Documents
:
|
6200277 - Lipase turbidimetric assay and acute pancreatitis. 1668287 - Natural killer cell activity in patients with adenocarcinoma in the upper gastrointesti... 2922967 - The anergic state as a predictor of pancreatic sepsis. 1648527 - Intraductal mucin-hypersecreting neoplasms of the pancreas. a clinicopathologic study o... 20224507 - Association of thrombotic and fibrinolytic factors with severity of culprit lesion in p... 6187427 - Radioimmunoassay of aldolase a. determination of normal serum levels and increased seru... |
Publication Detail:
|
Type: Consensus Development Conference; Journal Article; Practice Guideline |
Journal Detail:
|
Title: Revista brasileira de reumatologia Volume: 52 ISSN: 1809-4570 ISO Abbreviation: Rev Bras Reumatol Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-08-13 Completed Date: 2012-12-31 Revised Date: 2013-01-15 |
Medline Journal Info:
|
Nlm Unique ID: 0404256 Medline TA: Rev Bras Reumatol Country: Brazil |
Other Details:
|
Languages: eng; por Pagination: 474-95 Citation Subset: IM |
Affiliation:
|
Universidade do Sul de Santa Catarina, Florianópolis, SC, Brazil. ivanioreumato@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arthritis, Rheumatoid
/
complications*,
diagnosis,
therapy* Humans |
| Comments/Corrections | |
Erratum In:
|
Rev Bras Reumatol. 2012 Oct;52(5):815 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain.
Next Document: Assessment of different instruments used as outcome measures in patients with fibromyalgia.